Windy City Media Group Frontpage News

THE VOICE OF CHICAGO'S GAY, LESBIAN, BI, TRANS AND QUEER COMMUNITY SINCE 1985

home search facebook twitter join
Gay News Sponsor Windy City Times 2022-03-16
DOWNLOAD ISSUE
Donate

Sponsor
Sponsor
Sponsor

  WINDY CITY TIMES

Community Outraged at AIDS Drug Price Increase
by Bob Roehr
2003-12-31

This article shared 4221 times since Wed Dec 31, 2003
facebook twitter google +1 reddit email


Abbott Laboratories quietly increased the price of ritonavir (Norvir) by 400% Dec. 4, from $1.71 to $8.57 per 100 mg pill. The protease inhibitor (PI) primarily is used in sub-therapeutic doses with other protease inhibitors to delay their clearance by the liver. That means the price increase will be felt widely.

The AIDS community has only slowly become aware of the increase and is reacting with outrage and threats of boycott.

The company has asserted that the increase is a long-overdue price adjustment and reflects the cost of past research when they had to reformulate the compound. It also is not increasing the price to state-run AIDS drug assistance programs (ADAPs).

But many observers are calling it a ploy by Abbott to increase the market share of Kaletra, its other protease inhibitor. Kaletra had been losing ground to other PIs that have recently been approved for sale. This would boost the total cost of other PIs that must use Norvir as booster.

Michael Weinstein, president of the AIDS Healthcare Foundation, noted that even while the price of Norvir was skyrocketing, the price of Kaletra, which uses Norvir to boost its potency, did not increase at all.

'This is purely a marketing ploy to push for a larger market share for Kaletra by driving providers and patients to this cheaper Abbot combination therapy,' Weinstein said. 'The HIV community as a whole should unite and speak out against Abbott's bald-faced greed.'

'Abbott is feeding like a vulture on the bones of our healthcare system,' the AIDS Treatment Activists Coalition (ATAC) said in a flyer they are distributing about the price increase (see Web site www.atac-usa.org/Abbott%20Vulture.pdf).

ATAC, in a letter to Abbott dated Dec. 22, noted that tipranavir, a promising PI under development by Boehringer Ingelheim, uses 400 mg of Norvir daily. If the price increase stands and if tipranavir is approved by the FDA, its price would be about $20,000 a year, several times that of other currently available PIs.

'Abbott has changed the landscape of HIV/AIDS for the worse—is this what it wants to be known for?' asked ATAC. 'We believe that it is in the overall interests of your company to reconsider this shameful and destructive path.'

The HIV Medicine Association called on Abbott to rescind the price increase. 'It is critical that the implications of your actions on access to the majority of treatment regimens available to persons living with HIV/AIDS in the U.S. be given paramount consideration,' it wrote in a Dec. 18 letter to Abbott.

'This increase comes at a time when public programs that provide access to HIV treatment are struggling to keep costs down, and numerous ADAPs have been forced to impose eligibility and formulary restrictions and/or waiting lists.'

Howard Grossman, a physician in New York City with a large HIV practice, said in an e-mail he is 'going to refuse to have Abbott reps in my office and will try to find alternatives to any of their drugs I can.' He is asking the American Academy of HIV Medicine, where he serves as chair of the policy committee, to return funding from Abbott.

'To receive academic or financial support from Abbot Laboratories would be an insult to the many patients who this decision so greatly impacts,' Benjamin Young wrote to the company. The HIV doc and clinical instructor of medicine at the University of Colorado has rescinded any offer to lecture on behalf of the company, attend its advisory committee meetings, or support its research projects.

The London-based AIDSmap quoted one pharmaceutical company research scientist as saying, 'This isn't just an attack on competitors' pricing, it's an attack on their research strategies. Why bother investing in these areas if Abbott has effectively priced you out of the market?'

There is an unconfirmed report that the crusading New York Attorney General, Elliot Spitzer, has initiated an investigation into the price increase.

Grapefruit juice and a number of other drugs have an effect similar to Norvir in terms of slowing the liver's clearance of drugs such a PIs. But none of the alternatives have been studied and so there is no data on whether or how they might be substituted. Given Abbott's price increase, that is an area that researchers are likely to give new attention.


This article shared 4221 times since Wed Dec 31, 2003
facebook twitter google +1 reddit email

  ARTICLES YOU MIGHT LIKE

Gay News

Howard Brown Health unveils Pride mural at Walsh Park 2022-05-26
- On May 25, Howard Brown Health unveiled a mural celebrating Pride month, in collaboration with local artist David Anthony Geary. The unveiling took place at Walsh Park, 1722 N. Ashland Ave. Wintrust Bank's ongoing community partnership ...


Gay News

CDC publishes new HIV surveillance reports 2022-05-24
- The Centers for Disease Control and Prevention (CDC) published a new HIV surveillance report: Diagnoses of HIV Infection in the United States and Dependent Areas, 2020; and a new HIV supplemental surveillance report: Monitoring Selected National ...


Gay News

HIV/AIDS activist Rae Lewis-Thornton on her new memoir, 'Unprotected' 2022-05-18
- Emmy-winning HIV/AIDS activist, author, minister, political organizer, motivational speaker, life coach, jewelry designer and social media figure Rae Clara Lewis-Thornton's recently released book, Unprotected: A Memoir, is already a pre-release ...


Gay News

PASSAGES Dr. David Ostrow dies at 74 2022-05-14
- Longtime researcher Dr. David Gene Ostrow, of Chicago, died unexpectedly on Feb. 16 at home. He was 74. The cause of death was end-stage renal disease, according to the Tribute Archive website. Ostrow was born on ...


Gay News

Running squad 'Team to End AIDS' calls for participants to raise funds 2022-05-10
-- From a press release - (Chicago, IL) Over the last 19 years, TEAM TO ENDS AIDS (T2)—the only HIV charity fundraising marathon team in the Midwest—has raised more than $13 million for HIV/AIDS awareness and direct support for those living with ...


Gay News

Book-signing for HIV/AIDS activist's 'Unprotected: A Memoir' on May 21 2022-05-05
-- From a press release - "I had been torn apart by the doings of others and blamed myself for surviving to the best of my ability. It would literally take decades for me to understand that I was the product of what happened to me." Emmy ...


Gay News

NATIONAL Campus Pride, HIV and the military, IVF suit, Billie Jean King 2022-05-01
- Campus Pride—along with 36 other national/regional organizations such as GLSEN, PFLAG National and TransAthlete.com—requested that the National Center for Education Statistics (NCES) incorporate non-binary students into ...


Gay News

Indiana Univ. to host inaugural national HIV conference 2022-04-26
- Indiana University (IU) will host the first IU National HIV Conference, "Stepping into the 5th Decade: Evolving Our Response to HIV," June 8-11 in Indianapolis. Hosted by the Office of the Vice President for Diversity, Equity ...


Gay News

'It Was Vulgar and It Was Beautiful' explores art collective's part in HIV/AIDS activism 2022-04-23
- In Jack Lowery's book, It Was Vulgar and It Was Beautiful: How AIDS Activists Used Art to Fight a Pandemic, the historian shares how the art collective Gran Fury utilized community-made propaganda to address the HIV/AIDS ...


Gay News

Federal court strikes down Pentagon's restrictions on military service of people Living with HIV as unconstitutional 2022-04-07
-- From a press release - "The court ruled that the Pentagon's policies regarding service members with HIV are not only outdated, but unlawful, arbitrary and capricious, and unconstitutional . . . one of the strongest judicial rulings in over two decades ...


Gay News

Simmons measure passes Senate, would allow pharmacists to provide HIV testing, PrEP and PEP medications 2022-04-01
-- From a press release - SPRINGFIELD — To allow more people to access HIV preventative care easier, Illinois state Sen. Mike Simmons (D-Chicago) is leading a measure to allow pharmacists to provide HIV tests and preventative medications to help reduce new ...


Gay News

AFC calls on state legislature to pass Getting to Zero Illinois 2030 bills 2022-03-31
- AIDS Foundation Chicago (AFC) held its annual HIV Advocacy Day on March 9, saying it is focused on the Getting to Zero Illinois Plan (GTZ-IL) that aims to end the HIV epidemic in the state by ...


Gay News

San Francisco to host largest display of AIDS Memorial Quilt in a decade 2022-03-29
- The National AIDS Memorial will mark the 35th anniversary of the AIDS Memorial Quilt with an historic outdoor display in Golden Gate Park that will feature nearly 3,000 hand-stitched panels of the Quilt. The free public ...


Gay News

Elton John AIDS Foundation Academy Awards Viewing Party raises $8.6M 2022-03-28
- The 30th annual Elton John AIDS Foundation Academy Awards Viewing Party took place March 27 at West Hollywood Park, raising $8.6 million for the foundation's work to end AIDS. The event was hosted by 12-time Grammy-winning ...


Gay News

Legislation introduced to increase critical access to HIV prevention medications 2022-03-04
-- Press release from the Office of State Representative Kelly M. Cassidy 14th District - SPRINGFIELD Yesterday evening, HB4430 Increased Access to PrEP and PEP sponsored by Rep. Kelly M. Cassidy was brought to the Illinois House floor to continue to address the health disparities communities ...


 



Copyright © 2022 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 
 

TRENDINGBREAKINGPHOTOS






Donate


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots
Identity      BLACKlines      En La Vida      Archives      Advanced Search     
Windy City Queercast      Queercast Archives     
Press  Releases      Join WCMG  Email List      Email Blast      Blogs     
Upcoming Events      Todays Events      Ongoing Events      Bar Guide      Community Groups      In Memoriam     
Privacy Policy     

Windy City Media Group publishes Windy City Times,
The Bi-Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.